Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic Frozen Shoulder Patients.

Sponsor
South Valley University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05967923
Collaborator
(none)
40
1
3
16.4
2.4

Study Details

Study Description

Brief Summary

Patients will be divided randomly into 3 groups.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Shock wave therapy
  • Radiation: Low level lazer therapy
  • Other: Routine physical therapy program
N/A

Detailed Description

Patients will be allocated from out patient clinics of Qena university hospitals Then they will be randomly assigned to three groups, every one will contain 30 patients of both gender, with age range between 45 and 60 years old

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Group (a) Group (b) Group (c)Group (a) Group (b) Group (c)
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic
Actual Study Start Date :
Jul 5, 2023
Anticipated Primary Completion Date :
Oct 15, 2023
Anticipated Study Completion Date :
Nov 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group (a)

Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Radiation: Shock wave therapy
Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.
Other Names:
  • Non
  • Other: Routine physical therapy program
    Patients in this group will receive only routine physical therapy program three times a week for four weeks.

    Experimental: Group (b)

    Patients in this group will receive low level lazer therapy three times per week for four weeks in addition to routine physical therapy program.

    Radiation: Low level lazer therapy
    Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.
    Other Names:
  • Non
  • Other: Routine physical therapy program
    Patients in this group will receive only routine physical therapy program three times a week for four weeks.

    Experimental: Group (c)

    Patients in this group will receive only routine physical therapy program.

    Other: Routine physical therapy program
    Patients in this group will receive only routine physical therapy program three times a week for four weeks.

    Outcome Measures

    Primary Outcome Measures

    1. Shoulder joint Pain [4 weeks]

      By using visual analogue scale

    2. Range of motion of the shoulder [4 weeks]

      Range of shoulder internal and external rotation and shoulder flexion

    Secondary Outcome Measures

    1. Shoulder and hand disability [4 weeks]

      By using quick DASH questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients with diabetes mellitus.

    • patients with frozen shoulder due to diabetes mellitus.

    • patients age ranged between 45 and 60 years old.

    • cooperative patients.

    Exclusion Criteria:
    • patients with un-controlled hypertension.

    • patients sensetive to shock wave or lazer irradiation.

    • Patients with infectious skin diseases.

    • un-cooperative patients.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shymaa yussuf abo zaid Cairo Egypt

    Sponsors and Collaborators

    • South Valley University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Shymaa yussuf abo zaid, Lecturer, South Valley University
    ClinicalTrials.gov Identifier:
    NCT05967923
    Other Study ID Numbers:
    • P.T- ORTH-06/2023-516
    First Posted:
    Aug 1, 2023
    Last Update Posted:
    Aug 1, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Shymaa yussuf abo zaid, Lecturer, South Valley University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2023